Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lifitegrast speed of onset in dry eye
NCT04669561Phase 4Completed
- Sponsor
- Research Insight
- Start
- Mar 2021
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of lifitegrast in dry eye disease (DED), sponsored by Research Insight. Primary endpoint: Change in corneal higher order aberrations at 28 days. Started Mar 2021; status: completed.
02
Drugs
lifitegrast
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT04669561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04669561.